A cross sectional study to analyse the ADR reported in a hospital during the past three years

  • Sangeetha Sukumaran Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha
  • Varsha Elizabeth Joby Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha
  • Amala Joseph Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha
  • Aparna Jestin Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha
  • Jithin N P Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha
  • Sumayya B Muhammed Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha
  • Sunu Sebastian Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha
  • Jobin Kunjumon Vilapurathu Assistant Professor, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Abstract

Introduction: Cross sectional study is a type of observational study that analyzes data from apopulation, or a representative subset, at a specific point in time-that is, cross sectional data. The causality appraisal is assessment of the probability that the detected adverse event is produced by a specific medication. The most commonly used causality assessment scales are Naranjo Probability Scale and the World Health Organization-Uppsala Monitoring Centre (WHO-UMC) causality scales. The study is to analyze the adverse drug reaction reported in a hospital for the past three years. Aim: A cross sectional study to analyze the ADR reported in a hospital during the past three years. Methodology: A cross sectional observational study was conducted at Nirmala medical centre, Muvattupuzha. ADR reported in the past three years in this hospital were analyzed. Drug leading to ADR, department .gender, observed reaction, severity, Naranjo probability scale and WHO UMC causality assessment were done. Classification of drugs according to their drug class, classification of ADR according to the system, based on severity, sex, Naranjo score, WHO UMC criteria were done. The datas were analysed and represented into graphs. Result: A total of 342 ADR reports were analyzed in this study. The key findings of this study include: Skin-related ADRs were the most frequently reported, affecting 27.83% of cases. The majority of reported ADRs were of moderate severity (56.7%).Naranjo probability scale and WHO-UMC causality assessment indicated that most cases were in the probable category, with 63% and 76%, respectively. The general medicine department had the highest number of reported ADRs. Males accounted for the majority of reported ADRs (57.18%).Cardiovascular agents and antibiotics were the drug classes most commonly associated with reported ADRs, at 25.6% and 22.28%, respectively. Among cardiovascular agents, diuretics were found to be the primary culprits, causing 38.66% of reported ADRs. Conclusion: This study highlights the importance of monitoring, assessing, and documenting ADRs in healthcare facilities, as it provides valuable insights into the prevalence, severity, and causality of adverse drug reactions. This information can contribute to improving patient safety and the rational use of medications in clinical practice.

Keywords: ADR, Cross sectional study

Downloads

Download data is not yet available.

Author Biographies

Sangeetha Sukumaran, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Varsha Elizabeth Joby, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Amala Joseph, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Aparna Jestin, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Jithin N P, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Sumayya B Muhammed, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Sunu Sebastian, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Jobin Kunjumon Vilapurathu, Assistant Professor, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

Assistant Professor, Department of Pharmacy Practice, Nirmala College of Pharmacy, Muvattupuzha

References

1. Chhabra M, Jangra MS, Rashid M, Sharma P, Vidyasagar K. Pattern, severity, and outcome of adverse drug reactions in a tertiary care hospital: an evidence from a cross-sectional study. J Basic Clin Physiol Pharmacol. 2021 Jun 21:33(6):815-822. doi: 10.1515/jbepp-2020-0218. PMID: 34160928.
2. F. SH, V. S, R. JR. Analysis of adverse drug reactions encountered in a tertiary care hospital: a cross sectional study. Int J Basic Clin Pharmacol [Internet]. 2018 May 22 [cited 2022May11];7(6):1164-8Availablefrom: https://www.ijbcp.com/index.php/ijbcp/article/view/2532
3. Gupta SK, Kumar KD. An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study. Int J Pharm Investing. 2017 Oct-Dec;7(4):193-197. doi: 10.4103/jphi.JPHI_81_17. PMID: 29692979; PMCID: PMC5903024.
4. Remesh A, Balan A, Gnanadurai A. A cross-sectional study of surveillance of adverse drug reactions in inpatient departments of a tertiary care hospital. J Basic Clin Physiol Pharmacol. 2014 Feb;25(1):125-30. doi: 10.1515/jbcpp-2012-0077. PMID: 244234675. Geer MI, Koul PA, Tanki SA, Shah MY. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital. J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:323-34. 10.1016/j.vasen.2016.04.011. Epub 2016 Apr 20. PMID: 27109493. doi:
5. Jose J, Rao PG. Pattern of adverse drug reactions notified by spontaneousreporting in an Indian tertiary care teaching hospital. Pharmacol Res. 2006 Sep;54(3):226-33. doi: 10.1016/j.phrs.2006.05.003. Epub 2006 May 12. PMID: 16781163.
6. Kurian J, Mathew J, Sowjanya K, Chaitanya KR, Ramesh M, Sebastian J, Narayanappa D. Adverse Drug Reactions in Hospitalized Pediatric Patients: A Prospective Observational Study. Indian J Pediatr. 2016 May;83(5):414-9, doi:10.1007/s12098-015-2002-1. Epub 2016 Feb 26. PMID26916890. 8. Karaismailoglu B, Saltoglu N, Balkan II, Mete B, Tabak F. Ozturk R. A prospective pharmacovigilance study in the infectious diseases unit of a tertiary care hospital. J Infect Dev Ctries. 2019 Jul 31;13(7):649-655. doi: 10.3855/jide.11503. PMID: 32065823.
7. Shukla AK, Jhaj R, Misra S, Ahmed SN, Nanda M, Chaudhary D. Agreement between WHO-UMC causality scale and the Naranjo algorithm for causality assessment of adverse drug reactions. J Family Med Prim Care. 2021 Sep;10(9):3303-3308. doi: 10.4103/jfmpe.jfmpc_831 21. Epub 2021 Sep 30, PMID: 34760748; PMCID: PMC8565125.
8. Behera SK, Das S, Xavier AS, Velupula S, Sandhiya S. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm. 2018 Aug;40(4):903-910. doi: 10.1007/s11096-018-0694-9. Epub 2018 Jul 26. PMID: 30051231.
9. Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and fromthe evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther. 2003 Apr;28(2):137-43. doi:10.1046/j.1365-2710.2003.00475.x. PMID: 12713611
10. Behera SK, Das S, Xavier AS, Velupula S, Sandhiya S. Comparison of different methods for causality assessment of adverse drug reactions. Int J Clin Pharm. 2018 Aug:40(4):903-910. doi: 10.1007/s11096-018-0694-9. Epub 2018 Jul 26. PMID: 30051231.
11. Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther. 2003 Apr;28(2):137-43. doi: 10.1046/j.1365-2710.2003.00475.x. PMID: 12713611.
12. Dimri D, Raina RS, Thapliyal S, Thawani V. Retrospective Analysis of Pattern of Cutaneous Adverse Drug Reactions in Tertiary Hospital of Pauri Garhwal. J ClinDiagn Res. 2016 May;10(5):FC01-6. doi: 10.7860/JCDR/2016/16938.7736. Epub 2016 May 1. PMID: 27437240; PMCID: PMC4948416.
13. Vallano A, Cereza G, Pedrós C, Agusti A, Danés 1, Aguilera C. Arnau JM. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005 Dec;60(6):653-8. doi: 10.1111/j.1365- 2125.2005.02504.x. PMID: 16305591; PMCID: PMC1884880.
14. Parameswaran Nair N, Chalmers L, Bereznicki BJ, Curtain C, Peterson GM,Connolly M. Bereznicki LR. Adverse Drug Reaction-Related Hospitalizations in Elderly Australians: A Prospective Cross-Sectional Study in Two TasmanianHospitals. Drug Saf. 2017 Jul;40(7):597-606. doi: 10.1007/s40264-017-0528-z. PMID: 28382494. 15.
15. Shaikh SP,Nerurkar R. Adverse Drug Reaction Profile of Anticancer Agents in a Tertiary Care Hospital: An Observational Study. Curr Drug Saf. 2022;17(2):136- 142. doi: 10.2174/1574886316666210825122152. PMID: 34433404.
16. Sharma PK, Misra AK, Gupta A, Singh S, Dhamija P, Pareek P. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence. Indian J Pharmacol. 2018 Sep- Oct:50(5):273-278. doi: 10.4103/jp.LJP 544 17. PMID: 30636831; PMCID: PMC6302695
17. Saini VK, Sewal RK, Ahmad Y, Medhi B. Prospective Observational Study of Adverse Drug Reactions of Anticancer Drugs Used in Cancer Treatment in a Tertiary Care Hospital. Indian J Pharm Sci. 2015 Nov-Dec;77(6):687-93. doi: 10.4103/0250-474x.174990. PMID: 26997696; PMCID: PMC4778228.
18. Thakur R, Bajaj JK, Dutta A, Sidhu S. Retrospective Observational Study to Evaluate Causality, Preventability and Severity of Adverse Drug Reaction Associated with Anticancer Drugs in a Tertiary Care Hospital in Northern India. Curr Drug Saf. 2022;17(4):335-343. doi: 10.2174/1574886317666220216100515. PMID: 35170420.
19. Sharma A, Kumari KM, Manohar HD, Bairy KL, Thomas J. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care hospital in South India. Perspect Clin Res. 2015 Apr-Jun;6(2):109-15. doi: 10.4103/2229- 3485.154014. PMID: 25878957; PMCID: PMC4394577.
20. Rydberg DM, Holm L, Engqvist I, Fryckstedt J, Lindh JD, Stiller CO, Asker- Hagelberg C. Adverse Drug Reactions in a Tertiary Care Emergency Medicine Ward Prevalence, Preventability and Reporting. PLoS One. 2016 Sep 13;11(9):e0162948. doi: 10.1371/journal.pone.0162948. PMID: 27622270; PMCID: PMC5021364.
21. Haile DB, Ayen WY, Tiwari P. Prevalence and assessment of factors contributing to adverse drug reactions in wards of a tertiary care hospital, India. Ethiop J Health Sci. 2013 Mar23(1):39-48. PMID: 23559837; PMCID: PMC3613814.
22. Reza S M Rabbur, Lynne Emmerton, An introduction to adverse drug reaction reporting systems in different countries, International Journal of Pharmacy Practice, Volume 13, Issue 1, March 2005, Pages 91-100, https://doi.org/10.1211/0022357055821
23. Mulchandani, Rubina and Kakkar, Ashish Kumar. 'Reporting of Adverse Drug Reactions in India: A Review of the Current Scenario, Obstacles and Possible Solutions', 1 Jan. 2019: 33-44.
24. Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions:a challenge for pharmacovigilance in India.Indian J Pharmacol.2015 Jan – Feb;47(1):65-71.doi :10.4103/0253-7613.150344.PMID:25821314;PMCID:
Published
30/11/2023
Statistics
195 Views | 112 Downloads
Citatons
How to Cite
Sukumaran, S., Joby, V. E., Joseph, A. J., Jestin, A., P, J. N., Muhammed, S. B., Sebastian, S., & Vilapurathu, J. K. (2023). A cross sectional study to analyse the ADR reported in a hospital during the past three years . Journal of Innovations in Applied Pharmaceutical Science (JIAPS), 8(3-S), 85-89. https://doi.org/10.37022/jiaps.v8i3-S.530
Section
Research Article(S)